Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 20;13(13):1486.
doi: 10.3390/healthcare13131486.

Scoping Review of Letrozole in Assisted Reproductive Cycles: Efficacy and Outcomes Across Infertility Causes

Anastasios Potiris  1 , Efthalia Moustakli  2 , Fani Migka  3 , Athanasios Zikopoulos  1 , Chrysi Christodoulaki  1 , Argyro Papadopoulou  3 , Nikolaos Kathopoulis  3 , Charalampos Theofanakis  1 , Periklis Panagopoulos  1 , Ekaterini Domali  3 , Peter Drakakis  1 , Sofoklis Stavros  1
Affiliations
Review

Scoping Review of Letrozole in Assisted Reproductive Cycles: Efficacy and Outcomes Across Infertility Causes

Anastasios Potiris et al. Healthcare (Basel). .

Abstract

Background: Infertility affects 8-12% of couples globally, with causes including hormonal and structural abnormalities. Letrozole, an aromatase inhibitor, is commonly used for ovulation induction, but its role in various assisted reproductive technologies (ARTs) and across different subgroups of infertile women remains unclear. Objective: This scoping review aimed to map the existing evidence on the use of letrozole in assisted reproductive cycles, focusing on reproductive outcomes and its application across different patient populations. Methods: A scoping review was conducted following the PRISMA-ScR guidelines. Twelve studies-including randomized controlled trials and retrospective cohorts-were identified through a structured search strategy. Studies comparing letrozole alone or in combination with gonadotropins/clomiphene to other stimulation protocols were included. Data were charted across multiple outcomes including oocyte yield, implantation, pregnancy, miscarriage, and live birth rates. Results: Evidence suggests that letrozole-based protocols may enhance oocyte yield and improve reproductive outcomes in certain settings. The highest implantation rate (57%) was observed in natural cycles, while the letrozole-only group showed the highest clinical pregnancy (50.57%) and live birth rates (45.58%). Combination protocols achieved the highest ongoing pregnancy rate (58.3%), with the lowest miscarriage rate (14.86%) in the letrozole-only group. Conclusions: Letrozole appears to be a versatile agent in ART, especially for patients requiring reduced gonadotropin doses or estradiol modulation. This scoping review highlights the need for further research to clarify its optimal use across different infertility subgroups and ART modalities.

Keywords: aromatase inhibitors; assisted reproductive techniques (ART); infertility; letrozole; ovulation induction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram for the scoping review process.
Figure 2
Figure 2
This figure summarizes the benefits and drawbacks of letrozole.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Vander Borght M., Wyns C. Fertility and infertility: Definition and epidemiology. Clin. Biochem. 2018;62:2–10. doi: 10.1016/j.clinbiochem.2018.03.012. - DOI - PubMed
    1. Szamatowicz M. Assisted reproductive technology in reproductive medicine—Possibilities and limitations. Ginekol. Pol. 2016;87:820–823. doi: 10.5603/GP.2016.0095. - DOI - PubMed
    1. De Geyter C. Assisted reproductive technology: Impact on society and need for surveillance. Best. Pract. Res. Clin. Endocrinol. Metab. 2019;33:3–8. doi: 10.1016/j.beem.2019.01.004. - DOI - PubMed
    1. Evers J.L. Female subfertility. Lancet. 2002;360:151–159. doi: 10.1016/S0140-6736(02)09417-5. - DOI - PubMed
    1. Stavros S., Potiris A., Molopodi E., Mavrogianni D., Zikopoulos A., Louis K., Karampitsakos T., Nazou E., Sioutis D., Christodoulaki C., et al. Sperm DNA Fragmentation: Unraveling Its Imperative Impact on Male Infertility Based on Recent Evidence. Int. J. Mol. Sci. 2024;25:10167. doi: 10.3390/ijms251810167. - DOI - PMC - PubMed

LinkOut - more resources